Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials
From MaRDI portal
Publication:5438331
Recommendations
- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
- Adaptive clinical trial designs for phase I cancer studies
- A new look at evaluating MTD designs in cancer research
- The adaptive accelerated biased coin design for phase I clinical trials
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
Cites work
Cited in
(4)- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
- Review of Statistical Treatment for Oncology Dose-Escalation Trial with Prolonged Evaluation Window or Fast Enrollment
- Adaptive clinical trial designs for phase I cancer studies
- The adaptive accelerated biased coin design for phase I clinical trials
This page was built for publication: Statistical Properties of a Modified Accelerated Design for Phase I Cancer Clinical Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5438331)